Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

  1. Cools, F.
  2. Virdone, S.
  3. Sawhney, J.
  4. Lopes, R.D.
  5. Jacobson, B.
  6. Arcelus, J.I.
  7. Hobbs, F.D.R.
  8. Gibbs, H.
  9. Himmelreich, J.C.L.
  10. MacCallum, P.
  11. Schellong, S.
  12. Haas, S.
  13. Turpie, A.G.G.
  14. Ageno, W.
  15. Rocha, A.T.
  16. Kayani, G.
  17. Pieper, K.
  18. Kakkar, A.K.
  19. Avhad, A.
  20. Antunes, M.
  21. Thereza Rocha, A.
  22. Gonzales Lama, J.
  23. Abyankar, A.
  24. Kormann, A.P.M.
  25. Van Zyl, L.
  26. Kaul, U.
  27. Adams, F.
  28. Aloysius, I.
  29. Capehorn, M.
  30. Kumar, P.
  31. Mahajan, R.
  32. Show all authors +
Journal:
The Lancet Haematology

ISSN: 2352-3026

Year of publication: 2022

Volume: 9

Issue: 8

Pages: e594-e604

Type: Article

DOI: 10.1016/S2352-3026(22)00173-9 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus